Search

everythinglearnresearchcommunity

for

Search:↓

Nasopharyngeal carcinoma is a common cancer in Indonesia, with risk factors including genetics, diet, and Epstein-Barr virus, and is treated with advanced radiotherapy.

Trichilemmal carcinoma is rare, usually benign after removal, but needs close follow-up due to recurrence risks.

A reliable method was developed to measure dutasteride in tablets accurately and consistently.

Personalized treatment plans combining natural and synthetic approaches are important for managing alopecia effectively.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

The model and estimator can predict drug exposure in kidney transplant patients well.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

The drug combination was safe and showed promise in treating advanced tumors.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

The treatment is safe and shows promise for metastatic breast cancer.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.